No abstract available
Keywords:
Complement component 5 (C5) inhibitor; Gonorrhea; Humanized monoclonal antibody; Innate immunity; Sexually transmitted infection.
MeSH terms
-
Anti-Bacterial Agents / pharmacology
-
Anti-Bacterial Agents / therapeutic use
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Bacteremia / diagnosis*
-
Bacteremia / pathology
-
Complement Inactivating Agents / adverse effects*
-
Drug Resistance, Multiple, Bacterial
-
Gonorrhea / diagnosis*
-
Gonorrhea / pathology
-
Hemoglobinuria, Paroxysmal / drug therapy*
-
Humans
-
Male
-
Meningococcal Vaccines / adverse effects*
-
Microbial Sensitivity Tests
-
Neisseria gonorrhoeae / drug effects
-
Neisseria gonorrhoeae / isolation & purification*
-
Treatment Outcome
-
Young Adult
Substances
-
Anti-Bacterial Agents
-
Antibodies, Monoclonal, Humanized
-
Complement Inactivating Agents
-
Meningococcal Vaccines
-
ravulizumab